Study of Blood Samples in Patients With Breast Cancer
Recruitment status was Recruiting
RATIONALE: Studying the genes expressed in samples of blood from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to chemotherapy.
PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.
|Official Title:||Search for Genetic Factors Predictive of Response to Chemotherapy in Patients With or Who Has a Mammary Adenocarcinoma in Neo-adjuvant or Metastatic Setting|
- Histologic complete response (Chevallier and Sataloff) or tumor response (RECIST) [ Designated as safety issue: No ]
|Study Start Date:||November 2007|
|Estimated Primary Completion Date:||December 2011 (Final data collection date for primary outcome measure)|
- Identify constitutional gene variants associated with a change in response.
OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00959556
|Centre Oscar Lambret||Recruiting|
|Lille, France, 59020|
|Contact: Jacques Bonneterre, MD, PhD 33-3-20-29-5959 email@example.com|
|Principal Investigator:||Jacques Bonneterre, MD, PhD||Centre Oscar Lambret|